Search
Can supplements slow the progression of late-stage AMD?
Slowing geographic atrophy with supplements
New research has found that taking a daily vitamin and mineral supplement can slow the progression of late-stage dry age-related macular degeneration (AMD), otherwise known as geographic atrophy (GA).
Update in treatments for macular degeneration and what to expect in 2025
What is approved now, and what is coming soon
Professor Richard Gale covers all the exciting developments for wet and dry AMD, as well as diabetic macular oedema. From recently approved treatments in the UK to the growing role of biosimilars, you can find out about the progress being made. Professor Gale will also reveal what’s in the pipeline, and why there’s reason to feel hopeful for the future as we move into 2025 and beyond.
New approved treatment for wet AMD
What Lytenava approval means for NHS patients
Lytenava (bevacizumab gamma), is the first licensed version of Avastin for wet age-related macular degeneration. The treatment was approved by the National Institute for Health and Care Excellence (NICE) for use in the NHS last year.
Costs and benefits of wearable low vision aids
Which devices offer the best value for sight loss?
There are so many low vision aids (LVAs) on the market, making it difficult to know which one is right for you. But what really works? And which devices offer the best improvements to quality of life for those living with macular disease?
Could plants be used to treat macular disease?
How plants may help prevent abnormal blood vessel growth
Current treatments for wet age-related macular degeneration (AMD) have been life changing for many, helping to maintain vision. However, not all patients respond well to anti-VEGF injections, highlighting the need for alternative treatments. Professor Dulcie Mulholland and PhD student Elisha Griffin have been exploring whether 'homoisoflavonoids', found in rare hyacinth plants, could help prevent abnormal blood vessel growth in the macula.
Helping people with sight loss read more easily
How new techniques can ease reading for sight loss
Reading can be difficult for people with central vision loss, as damage to the macula affects natural eye movement - making reading slow, tiring, and less enjoyable. Our upcoming webinar will explore a new technique that moves text on a screen in a way that mimics how healthy eyes naturally scan and pause. This technique called Biomimetic Scrolling (BMS) is designed to make reading faster, easier, and more comfortable for people with sight loss.
Understanding Charles Bonnet Syndrome
Why people with sight loss can experience visual hallucinations
Why do some people with vision loss experience hallucinations, while others do not?
Exploring clinical trials
How clinical trials help improve treatments
What are clinical trials? How do they work and what role do they play in improving healthcare? Geraldine Hoad and Sarah Clinton from the Macular Society’s research team join us to discuss the types of trials currently taking place in the UK and how you could get involved.
Genetic counselling for macular disease
What is a genetic counsellor and what genetic tests are available?
Elena Schiff is a genetic counsellor at Moorfields Eye Hospital and joins us to discuss what a genetic counsellor does, the chances of inheriting macular disease and the different genetic tests available. She will also cover what the results might mean, as well as the emotional impact that knowing this information can have.
What are the benefits of registering as sight impaired?
What role do CVIs play when seeking support for sight loss?
A Certificate of Visual Impairment (CVI) can play an important role in ensuring people with sight loss receive the support they need. It can open up access to practical, financial, and emotional support, while also providing data to improve eye health services across the UK.